Will Genpact (G) stock recover?
What do analysts say about G?
Average price target from 7 analysts: $39 over ~12 months (Hold consensus), i.e. +11 % from the current price. Most reliable firm on G: BMO Capital (100% hit rate, 2 scored calls). A target is a 12-month view, not for tomorrow.
What happened after its past drops?
Genpact has only had 2 drops of 30%+ over 2013-2026 — too few to draw a reliable trend. (monthly history 2013-2026 — transparency data, not a guarantee)
G's biggest months
⚠️ Drop measured from the 12-month high; analyst targets on a ~12-month horizon; monthly history since 2013. Information, not investment advice. Past performance does not guarantee future results.
Frequently asked questions
Will Genpact stock recover?
No one can guarantee it, and we won't. What we know: it's down 30 % from its high; analysts target $39 over 12 months (+11 % from the current price). Genpact has only had 2 drops of 30%+ over 2013-2026 — too few to draw a reliable trend. Past performance does not guarantee future results.
Why has G dropped so much?
We don't assert the cause of a drop — a headline can be a consequence or a coincidence. What we measure is what comes next: the analysts' target and the stock's historical behavior after this kind of drop.
Should I buy G now that it's down?
A drop is not a buy signal by itself. Cross-check with the analysts' target, their real reliability on the stock (most solid: BMO Capital, 100% hit rate), and the fundamentals. This is not personalized advice.